相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Empagliflozin improves endothelial and cardiomyocyte function in human heart failure with preserved ejection fraction via reduced pro-inflammatory-oxidative pathways and protein kinase Gα oxidation
Detmar Kolijn et al.
CARDIOVASCULAR RESEARCH (2021)
Metabolic inflammation in heart failure with preserved ejection fraction
Gabriele G. Schiattarella et al.
CARDIOVASCULAR RESEARCH (2021)
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure
Sandor Batkai et al.
EUROPEAN HEART JOURNAL (2021)
Computational methods and next-generation sequencing approaches to analyze epigenetics data: Profiling of methods and applications
Itika Arora et al.
METHODS (2021)
Myocardial Gene Expression Signatures in Human Heart Failure With Preserved Ejection Fraction
Virginia S. Hahn et al.
CIRCULATION (2021)
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jorg Taubel et al.
EUROPEAN HEART JOURNAL (2021)
CDR132L improves systolic and diastolic function in a large animal model of chronic heart failure
Sandor Batkai et al.
EUROPEAN HEART JOURNAL (2021)
Novel antisense therapy targeting microRNA-132 in patients with heart failure: results of a first-in-human Phase 1b randomized, double-blind, placebo-controlled study
Jorg Taubel et al.
EUROPEAN HEART JOURNAL (2021)
Natural Compound Library Screening Identifies New Molecules for the Treatment of Cardiac Fibrosis and Diastolic Dysfunction
Katharina Schimmel et al.
CIRCULATION (2020)
Abstract 11: Prospective Association of Tet2 Mediated Clonal Hematoopoiesis and Heart Failure and Its Subtypes in Postmenopausal Women
Chuck Eaton et al.
CIRCULATION (2020)
How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
Burkert Pieske et al.
EUROPEAN JOURNAL OF HEART FAILURE (2020)
Epigenetic-sensitive pathways in personalized therapy of major cardiovascular diseases
Concetta Schiano et al.
PHARMACOLOGY & THERAPEUTICS (2020)
HDAC inhibition improves cardiopulmonary function in a feline model of diastolic dysfunction
Markus Wallner et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Preclinical development of a miR-132 inhibitor for heart failure treatment
Ariana Foinquinos et al.
NATURE COMMUNICATIONS (2020)
From traditional pharmacological towards nucleic acid-based therapies for cardiovascular diseases
Ulf Landmesser et al.
EUROPEAN HEART JOURNAL (2020)
Effect of Apabetalone Added to Standard Therapy on Major Adverse Cardiovascular Events in Patients With Recent Acute Coronary Syndrome and Type 2 Diabetes A Randomized Clinical Trial
Kausik K. Ray et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Modulation of Titin-Based Stiffness in Hypertrophic Cardiomyopathy via Protein Kinase D
Melissa Herwig et al.
FRONTIERS IN PHYSIOLOGY (2020)
Targeting muscle-enriched long non-coding RNA H19 reverses pathological cardiac hypertrophy
Janika Viereck et al.
EUROPEAN HEART JOURNAL (2020)
Hemodynamic and Functional Impact of Epicardial Adipose Tissue in Heart Failure With Preserved Ejection Fraction
Katlyn E. Koepp et al.
JACC-HEART FAILURE (2020)
DNA methylation patterns from peripheral blood separate coronary artery disease patients with and without heart failure
Chris R. Bain et al.
ESC HEART FAILURE (2020)
Microbiota-derived metabolite promotes HDAC3 activity in the gut
Shu-en Wu et al.
NATURE (2020)
Regulation of titin-based cardiac stiffness by unfolded domain oxidation (UnDOx)
Christine M. Loescher et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Epigenetic Control of Mitochondrial Function in the Vasculature
Shafeeq A. Mohammed et al.
FRONTIERS IN CARDIOVASCULAR MEDICINE (2020)
Deletion of delta-like 1 homologue accelerates fibroblast-myofibroblast differentiation and induces myocardial fibrosis
Patricia Rodriguez et al.
EUROPEAN HEART JOURNAL (2019)
Epigenetic processing in cardiometabolic disease
Sarah Costantino et al.
ATHEROSCLEROSIS (2019)
Clonal Hematopoiesis and Its Impact on Cardiovascular Disease
Soichi Sano et al.
CIRCULATION JOURNAL (2019)
Targeted DNA Methylation Profiling of Human Cardiac Tissue Reveals Novel Epigenetic Traits and Gene Deregulation Across Different Heart Failure Patient Subtypes
Nadezhda Glezeva et al.
CIRCULATION-HEART FAILURE (2019)
The Effects of Resveratrol in Patients with Cardiovascular Disease and Heart Failure: A Narrative Review
Garrison J. B. Dyck et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Epigenetic changes in healthy human skeletal muscle following exercise- a systematic review
Macsue Jacques et al.
EPIGENETICS (2019)
HDAC inhibition induces autophagy and mitochondrial biogenesis to maintain mitochondrial homeostasis during cardiac ischemia/reperfusion injury
Jing Yang et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Epigenetic therapies in heart failure
Michael Alexanian et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)
Intestinal Microbiota in Cardiovascular Health and Disease
W. H. Wilson Tang et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Advances in epigenetics link genetics to the environment and disease
Giacomo Cavalli et al.
NATURE (2019)
SIRT1 activation attenuates cardiac fibrosis by endothelial-to-mesenchymal transition
Zhen-Hua Liu et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
Domenico D'Amario et al.
FRONTIERS IN PHYSIOLOGY (2019)
Obesity-induced activation of JunD promotes myocardial lipid accumulation and metabolic cardiomyopathy
Sarah Costantino et al.
EUROPEAN HEART JOURNAL (2019)
The role of adipose tissue in cardiovascular health and disease
Evangelos K. Oikonomou et al.
NATURE REVIEWS CARDIOLOGY (2019)
Clinical epigenetics: seizing opportunities for translation
Maria Berdasco et al.
NATURE REVIEWS GENETICS (2019)
Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic lschemic Heart Failure
Lena Dorsheimer et al.
JAMA CARDIOLOGY (2019)
HDAC inhibitor valproic acid protects heart function through Foxm1 pathway after acute myocardial infarction
Shuo Tian et al.
EBIOMEDICINE (2019)
Heart Failure with Reduced Ejection Fraction (HFrEF) and Preserved Ejection Fraction (HFpEF): The Diagnostic Value of Circulating MicroRNAs
Yei-Tsung Chen et al.
CELLS (2019)
JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure
Soichi Sano et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Epigenetics in Cardiac Hypertrophy and Heart Failure
Chia-Feng Liu et al.
JACC-BASIC TO TRANSLATIONAL SCIENCE (2019)
Epigenetics and precision medicine in cardiovascular patients: from basic concepts to the clinical arena
Sarah Costantino et al.
EUROPEAN HEART JOURNAL (2018)
Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives
Wolfgang Poller et al.
EUROPEAN HEART JOURNAL (2018)
Circulating microRNAs as novel biomarkers for heart failure
Feng Chen et al.
HELLENIC JOURNAL OF CARDIOLOGY (2018)
Pathophysiological understanding of HFpEF: microRNAs as part of the puzzle
Monika Rech et al.
CARDIOVASCULAR RESEARCH (2018)
Non-coding RNAs in vascular disease - from basic science to clinical applications: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology
Jan Fiedler et al.
CARDIOVASCULAR RESEARCH (2018)
miR-29 contributes to normal endothelial function and can restore it in cardiometabolic disorders
Michael E. Widlansky et al.
EMBO MOLECULAR MEDICINE (2018)
NADPH oxidase 4 and endothelial nitric oxide synthase contribute to endothelial dysfunction mediated by histone methylations in metabolic memory
Yunfei Liao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Towards a complete map of the human long non-coding RNA transcriptome
Barbara Uszczynska-Ratajczak et al.
NATURE REVIEWS GENETICS (2018)
Histone deacetylase activity governs diastolic dysfunction through a nongenomic mechanism
Mark Y. Jeong et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Distinct epigenetic programs regulate cardiac myocyte development and disease in the human heart in vivo
Ralf Gilsbach et al.
NATURE COMMUNICATIONS (2018)
The lncRNA GATA6-AS epigenetically regulates endothelial gene expression via interaction with LOXL2
Philipp Neumann et al.
NATURE COMMUNICATIONS (2018)
Transgenerational Epigenetic Inheritance
Ana Boskovic et al.
ANNUAL REVIEW OF GENETICS, VOL 52 (2018)
Epigenetic Regulation of Endothelial-to-Mesenchymal Transition in Chronic Heart Disease: Histone Modifications, DNA Methylation, and Noncoding RNAs
Melanie S. Hulshoff et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
GLP-1 treatment protects endothelial cells from oxidative stress-induced autophagy and endothelial dysfunction
Xiangsheng Cai et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
Combination of Plasma Biomarkers and Clinical Data for the Detection of Myocardial Fibrosis or Aggravation of Heart Failure Symptoms in Heart Failure with Preserved Ejection Fraction Patients
Cho-Kai Wu et al.
JOURNAL OF CLINICAL MEDICINE (2018)
Endothelin-1 Regulation Is Entangled in a Complex Web of Epigenetic Mechanisms in Diabetes
S. Biswas et al.
PHYSIOLOGICAL RESEARCH (2018)
AGEs Decreased SIRT3 Expression and SIRT3 Activation Protected AGEs-Induced EPCs' Dysfunction and Strengthened Anti-oxidant Capacity
Mingze Chang et al.
INFLAMMATION (2017)
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
Yu Zhang et al.
ENDOCRINE REVIEWS (2017)
New insights into epigenetic modifications in heart failure
Yongming Li et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The long noncoding RNA Wisper controls cardiac fibrosis and remodeling
Rudi Micheletti et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure
Qiming Duan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
The epigenetic promise to improve prognosis of heart failure and heart transplantation
Chiara Sabia et al.
TRANSPLANTATION REVIEWS (2017)
Circular RNAs in Cardiovascular Disease: An Overview
Ximin Fan et al.
BIOMED RESEARCH INTERNATIONAL (2017)
Emerging Evidence of Epigenetic Modifications in Vascular Complication of Diabetes
Madhu Khullar et al.
FRONTIERS IN ENDOCRINOLOGY (2017)
MALAT1 Modulates TGF-beta 1 nduced Endothelial-to-Mesenchymal Transition through Downregulation of miR-145
Yin Xiang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and a Novel Class of Biomarkers for Heart Failure
Benjamin Meder et al.
CIRCULATION (2017)
Reversal of pathological cardiac hypertrophy via the MEF2-coregulator interface
Jianqin Wei et al.
JCI INSIGHT (2017)
Impact of Glycemic Variability on Chromatin Remodeling, Oxidative Stress, and Endothelial Dysfunction in Patients With Type 2 Diabetes and With Target HbA1c Levels
Sarah Costantino et al.
DIABETES (2017)
Inhibition of the Cardiac Fibroblast- Enriched lncRNA Meg3 Prevents Cardiac Fibrosis and Diastolic Dysfunction
Maria-Teresa Piccoli et al.
CIRCULATION RESEARCH (2017)
Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy
Suchi Raghunathan et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2017)
α-B Crystallin Reverses High Diastolic Stiffness of Failing Human Cardiomyocytes
Constantijn Franssen et al.
CIRCULATION-HEART FAILURE (2017)
Epigenetic Therapy for the Treatment of Hypertension-Induced Cardiac Hypertrophy and Fibrosis
Chris J. Watson et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2016)
P66Shc-Induced MicroRNA-34a Causes Diabetic Endothelial Dysfunction by Downregulating Sirtuin1
Qiuxia Li et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Long noncoding RNA-MEG3 is involved in diabetes mellitus-related microvascular dysfunction
Gui-Zhen Qiu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
Matthew W. Snyder et al.
CELL (2016)
The Role of DNA Methylation in Cardiovascular Risk and Disease Methodological Aspects, Study Design, and Data Analysis for Epidemiological Studies
Jia Zhong et al.
CIRCULATION RESEARCH (2016)
Epigenetic regulation in heart failure
Soo Young Kim et al.
CURRENT OPINION IN CARDIOLOGY (2016)
Hypoxia-induced endothelial-mesenchymal transition is associated with RASAL1 promoter hypermethylation in human coronary endothelial cells
Xingbo Xu et al.
FEBS LETTERS (2016)
MicroRNA-503 promotes angiotensin II-induced cardiac fibrosis by targeting Apelin-13
Yuhong Zhou et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Physiological and pathological cardiac hypertrophy
Ippei Shimizu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2016)
Maternal folic acid supplementation modulates DNA methylation and gene expression in the rat offspring in a gestation period-dependent and organ-specific manner
Anna Ly et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2016)
Long Noncoding RNAs From Clinical Genetics to Therapeutic Targets?
Reinier A. Boon et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
The long noncoding RNA Chaer defines an epigenetic checkpoint in cardiac hypertrophy
Zhihua Wang et al.
NATURE MEDICINE (2016)
Aging and peripheral lipopolysaccharide can modulate epigenetic regulators and decrease IL-1β promoter DNA methylation in microglia
Stephanie M. Matt et al.
NEUROBIOLOGY OF AGING (2016)
Long noncoding RNA Chast promotes cardiac remodeling
Janika Viereck et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Genome-wide DNA methylation pattern in visceral adipose tissue differentiates insulin-resistant from insulin-sensitive obese subjects
A. B. Crujeiras et al.
TRANSLATIONAL RESEARCH (2016)
Myocardial Microvascular Inflammatory Endothelial Activation in Heart Failure With Preserved Ejection Fraction
Constantijn Franssen et al.
JACC-HEART FAILURE (2016)
Epigenetics in heart failure phenotypes
Alexander Berezin
BBA CLINICAL (2016)
The role of sirtuins in cardiac disease
Shouji Matsushima et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2015)
Therapeutic potential of resveratrol in heart failure
Miranda M. Sung et al.
RESVERATROL AND HEALTH (2015)
Epigenetic balance of aberrant Rasal1 promoter methylation and hydroxymethylation regulates cardiac fibrosis
Xingbo Xu et al.
CARDIOVASCULAR RESEARCH (2015)
Epigenetics and Metabolism
Samuel T. Keating et al.
CIRCULATION RESEARCH (2015)
Targeting Chromatin Remodeling to Prevent Cardiovascular Disease in Diabetes
Sarah Costantino et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2015)
Protective effects of sirtuins in cardiovascular diseases: from bench to bedside
Stephan Winnik et al.
EUROPEAN HEART JOURNAL (2015)
Circulating microRNAs in heart failure with reduced and preserved left ventricular ejection fraction
Lee Lee Wong et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
MicroRNA signatures differentiate preserved from reduced ejection fraction heart failure
Chris J. Watson et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
Epigenetic regulation of endothelial-cell-mediated vascular repair
Sylvain Fraineau et al.
FEBS JOURNAL (2015)
Sulforaphane Protects against Cardiovascular Disease via Nrf2 Activation
Yang Bai et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
Epigallocatechin-3-gallate inhibits VCAM-1 expression and apoptosis induction associated with LC3 expressions in TNFα-stimulated human endothelial cells
Kazuo Yamagata et al.
PHYTOMEDICINE (2015)
Mitochondrial epigenetics: an overlooked layer of regulation?
Monique G. P. van der Wijst et al.
TRENDS IN GENETICS (2015)
Tumour necrosis factor-alpha participates on the endothelin-1/nitric oxide imbalance in small arteries from obese patients: role of perivascular adipose tissue
Agostino Virdis et al.
EUROPEAN HEART JOURNAL (2015)
A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice
Ravi Jahagirdar et al.
ATHEROSCLEROSIS (2014)
The histone acetyltransferase MOF overexpression blunts cardiac hypertrophy by targeting ROS in mice
Weiwei Qiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Inhibition of DNA methylation reverses norepinephrine-induced cardiac hypertrophy in rats
DaLiao Xiao et al.
CARDIOVASCULAR RESEARCH (2014)
S-Glutathionylation of Cryptic Cysteines Enhances Titin Elasticity by Blocking Protein Folding
Jorge Alegre-Cebollada et al.
CELL (2014)
Gigantic Business Titin Properties and Function Through Thick and Thin
Wolfgang A. Linke et al.
CIRCULATION RESEARCH (2014)
Interstitial Fibrosis, Left Ventricular Remodeling, and Myocardial Mechanical Behavior in a Population-Based Multiethnic Cohort The Multi-Ethnic Study of Atherosclerosis (MESA) Study
Sirisha Donekal et al.
CIRCULATION-CARDIOVASCULAR IMAGING (2014)
Hypoxia-induced epigenetic modifications are associated with cardiac tissue fibrosis and the development of a myofibroblast-like phenotype
Chris J. Watson et al.
HUMAN MOLECULAR GENETICS (2014)
Human myocytes are protected from titin aggregation-induced stiffening by small heat shock proteins
Sebastian Koetter et al.
JOURNAL OF CELL BIOLOGY (2014)
Cardiac miR-133a overexpression prevents early cardiac fibrosis in diabetes
Shali Chen et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy
Claudia Bang et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Leptin induces cardiac fibrosis through galectin-3, mTOR and oxidative stress: potential role in obesity
Ernesto Martinez-Martinez et al.
JOURNAL OF HYPERTENSION (2014)
Sulforaphane Inhibits TNF-α-Induced Adhesion Molecule Expression Through the Rho A/ROCK/NF-κB Signaling Pathway
Chi-Nan Hung et al.
JOURNAL OF MEDICINAL FOOD (2014)
A long noncoding RNA protects the heart from pathological hypertrophy
Pei Han et al.
NATURE (2014)
SIRT1 Functions as an Important Regulator of Estrogen-Mediated Cardiomyocyte Protection in Angiotensin II-Induced Heart Hypertrophy
Tao Shen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2014)
DNMT3A silencing RASSF1A promotes cardiac fibrosis through upregulation of ERK1/2
Hui Tao et al.
TOXICOLOGY (2014)
Pathogenic role of lncRNA-MALAT1 in endothelial cell dysfunction in diabetes mellitus
J-Y Liu et al.
CELL DEATH & DISEASE (2014)
Lysine methyltransferase Smyd2 regulates Hsp90-mediated protection of the sarcomeric titin springs and cardiac function
Tobias Voelkel et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction
Nazha Hamdani et al.
CARDIOVASCULAR RESEARCH (2013)
Crucial Role for Ca2+/Calmodulin-Dependent Protein Kinase-II in Regulating Diastolic Stress of Normal and Failing Hearts via Titin Phosphorylation
Nazha Hamdani et al.
CIRCULATION RESEARCH (2013)
MicroRNA-22 Regulates Cardiac Hypertrophy and Remodeling in Response to Stress
Zhan-Peng Huang et al.
CIRCULATION RESEARCH (2013)
Alterations in cardiac DNA methylation in human dilated cardiomyopathy
Jan Haas et al.
EMBO MOLECULAR MEDICINE (2013)
Oral resveratrol and calcium fructoborate supplementation in subjects with stable angina pectoris: Effects on lipid profiles, inflammation markers, and quality of life
Constantin Militaru et al.
NUTRITION (2013)
High Glucose Induced Alteration of SIRTs in Endothelial Cells Causes Rapid Aging in a p300 and FOXO Regulated Pathway
Rokhsana Mortuza et al.
PLOS ONE (2013)
Genome-wide analysis of histone marks identifying an epigenetic signature of promoters and enhancers underlying cardiac hypertrophy
Roberto Papait et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Transforming Growth Factor-β-Induced Endothelial-to-Mesenchymal Transition Is Partly Mediated by MicroRNA-21
Regalla Kumarswamy et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Cardiomyocyte overexpression of miR-27b induces cardiac hypertrophy and dysfunction in mice
Jian Wang et al.
CELL RESEARCH (2012)
Primary Prevention of Atherosclerosis A Clinical Challenge for the Reversal of Epigenetic Mechanisms?
Claudio Napoli et al.
CIRCULATION (2012)
Redox Mediating Epigenetic Changes Confer Metabolic Memories
Assam El-Osta
CIRCULATION RESEARCH (2012)
Smyd2 controls cytoplasmic lysine methylation of Hsp90 and myofilament organization
Laura T. Donlin et al.
GENES & DEVELOPMENT (2012)
Two-step epigenetic Mendelian randomization: a strategy for establishing the causal role of epigenetic processes in pathways to disease
Caroline L. Relton et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
MicroRNA-24 regulates cardiac fibrosis after myocardial infarction
Jue Wang et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2012)
MiR-133a regulates collagen 1A1: Potential role of miR-133a in myocardial fibrosis in angiotensin II-dependent hypertension
Giovanna Castoldi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
Attenuation of MicroRNA-22 derepressed PTEN to effectively protect rat cardiomyocytes from hypertrophy
Xu-Dong Xu et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2012)
The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun
Nagalingam R. Sundaresan et al.
NATURE MEDICINE (2012)
Epigenetics and the environment: emerging patterns and implications
Robert Feil et al.
NATURE REVIEWS GENETICS (2012)
The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Ahmet Ucar et al.
NATURE COMMUNICATIONS (2012)
Diabetes Mellitus and Myocardial Mitochondrial Dysfunction: Bench to Bedside
Alexandra Koenig et al.
HEART FAILURE CLINICS (2012)
Homocysteine promotes human endothelial cell dysfunction via site-specific epigenetic regulation of p66shc
Cuk-Seong Kim et al.
CARDIOVASCULAR RESEARCH (2011)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
Cardiac Dysfunction and Noncardiac Dysfunction as Precursors of Heart Failure With Reduced and Preserved Ejection Fraction in the Community
Carolyn S. P. Lam et al.
CIRCULATION (2011)
Therapeutic Inhibition of miR-208a Improves Cardiac Function and Survival During Heart Failure
Rusty L. Montgomery et al.
CIRCULATION (2011)
Epigenetic Modifications Basic Mechanisms and Role in Cardiovascular Disease
Diane E. Handy et al.
CIRCULATION (2011)
Cardiac Inflammation Contributes to Changes in the Extracellular Matrix in Patients With Heart Failure and Normal Ejection Fraction
Dirk Westermann et al.
CIRCULATION-HEART FAILURE (2011)
Heart failure with preserved ejection fraction: pathophysiology, diagnosis, and treatment
Barry A. Borlaug et al.
EUROPEAN HEART JOURNAL (2011)
DOT1L regulates dystrophin expression and is critical for cardiac function
Anh T. Nguyen et al.
GENES & DEVELOPMENT (2011)
The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice
Qing-Jun Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension
Douglas D. Lemon et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Diastolic Tissue Doppler Indexes Correlate With the Degree of Collagen Expression and Cross-Linking in Heart Failure and Normal Ejection Fraction
Mario Kasner et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2011)
Targeting Inflammation in Heart Failure with Histone Deacetylase Inhibitors
Timothy A. McKinsey
MOLECULAR MEDICINE (2011)
Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure
Stephanie Rimbaud et al.
PLOS ONE (2011)
DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria
Lisa S. Shock et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats
Abishek Iyer et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice
Wen-Feng Cai et al.
CARDIOVASCULAR RESEARCH (2010)
Exercise Hemodynamics Enhance Diagnosis of Early Heart Failure With Preserved Ejection Fraction
Barry A. Borlaug et al.
CIRCULATION-HEART FAILURE (2010)
Culprit Mechanism(s) for Exercise Intolerance in Heart Failure With Normal Ejection Fraction
Walter J. Paulus
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Differential DNA Methylation Correlates with Differential Expression of Angiogenic Factors in Human Heart Failure
Mehregan Movassagh et al.
PLOS ONE (2010)
Modulation of Titin-Based Stiffness by Disulfide Bonding in the Cardiac Titin N2-B Unique Sequence
Anika Gruetzner et al.
BIOPHYSICAL JOURNAL (2009)
Genome-wide histone methylation profile for heart failure
Ruri Kaneda et al.
GENES TO CELLS (2009)
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice
Thomas E. Callis et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
MicroRNA-1 Negatively Regulates Expression of the Hypertrophy-Associated Calmodulin and Mef2a Genes
Sadakatsu Ikeda et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
Inhibition of class I histone deacetylase with an apicidin derivative prevents cardiac hypertrophy and failure
Pasquale Gallo et al.
CARDIOVASCULAR RESEARCH (2008)
A redox-dependent pathway for regulating class IIHDACs and cardiac hypertrophy
Tetsuro Ago et al.
CELL (2008)
SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70
Nagalingam R. Sundaresan et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thomas Thum et al.
NATURE (2008)
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CaMKIIδ isoforms differentially affect calcium handling but similarly regulate HDAC/MEF2 transcriptional responses
Tong Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Myocardial matrix remodeling and the matrix metalloproteinases: Influence on cardiac form and function
Francis G. Spinale
PHYSIOLOGICAL REVIEWS (2007)
Epigenetic regulation of tumor necrosis factor alpha
K. E. Sullivan et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3β activity
Chinmay M. Trivedi et al.
NATURE MEDICINE (2007)
Role of gender in heart failure with normal left ventricular ejection fraction
Vera Regitz-Zagrosek et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2007)
A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure
Eva van Rooij et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Mechanisms of diastolic dysfunction in heart failure
Barry A. Borlaug et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
Theophilus E. Owan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Histone H2A.z is essential for cardiac myocyte hypertrophy but opposed by silent information regulator 2α
Ieng-Yi Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Heart failure - Current perspectives in diastolic dysfunction and diastolic heart failure
AF Leite-Moreira
HEART (2006)
Myocardial structure and function differ in systolic and diastolic heart failure
L van Heerebeek et al.
CIRCULATION (2006)
Epigenetics and human disease: translating basic biology into clinical applications
D Rodenhiser et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2006)
In vivo chromatin remodeling events leading to inflammatory gene transcription under diabetic conditions
F Miao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Association of the chaperone αB-crystallin with titin in heart muscle
B Bullard et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Endothelial nitric oxide synthase overexpression attenuates congestive heart failure in mice
SP Jones et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The transcriptional co-activators CREB-binding protein (CBP) and p300 play a critical role in cardiac hypertrophy that is dependent on their histone acetyltransferase activity
RJ Gusterson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy
CL Zhang et al.
CELL (2002)
分享论文
